The first genetic characterization of a D4 measles virus strain derived from a patient with subacute sclerosing panencephalitis

Infection, Genetics and Evolution

Volumn 17, Issue , 2013, Pages 71-78

  Ivancic Jelecki, Jelena ^a   Baricevic, Marijana ^a,e   Šantak, Maja ^a   Harcet, Matija ^b   Tešović, Goran ^c   Marusic Della Marina, Branka ^d   Forcic, Dubravko ^a  

^a INSTITUTE OF IMMUNOLOGY   (Croatia)

^b RUDER BO KOVI INSTITUTE   (Croatia)

^c Croatia   (Croatia)

^d Alergologiju I Reumatologiju S Klini kom Imunologijom   (Croatia)

^e University of Zagreb   (Croatia)

Author keywords

D4 genotype; Genetic characterization; Measles virus; SSPE

Indexed keywords

GLYCINE DEHYDROGENASE (DECARBOXYLATING); MATRIX PROTEIN; VIRUS HEMAGGLUTININ;

AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; GENE SEQUENCE; GENETIC ANALYSIS; GENOTYPE; HUMAN; HUMAN TISSUE; MATRIX GENE; MEASLES VIRUS; MOLECULAR PHYLOGENY; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; P GENE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SUBACUTE SCLEROSING PANENCEPHALITIS; UNINDEXED SEQUENCE; VIRAL GENETICS; VIRUS GENE; VIRUS HEMAGGLUTININ GENE; VIRUS MUTATION; VIRUS STRAIN;

AMINO ACID SUBSTITUTION; GENES, VIRAL; GENETIC VARIATION; GENOTYPE; HUMANS; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; PHYLOGENY; SSPE VIRUS; SUBACUTE SCLEROSING PANENCEPHALITIS; VIRAL PROTEINS;

MEASLES VIRUS;

EID: 84876705465     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2013.03.032     Document Type: Article

References (63)

1. Anlar B., Yalaz K., Oktem F., Köse G. Long-term follow-up of patients with subacute sclerosing panencephalitis treated with intraventricular alpha-interferon. Neurology 1997, 48:526-528.
2. Ayata M., Kimoto T., Hayashi K., Seto T., Murata R., Ogura H. Nucleotide sequences of the matrix protein gene of subacute sclerosing panencephalitis viruses compared with local contemporary isolates from patients with acute measles. Virus Res. 1998, 54:107-115.
3. Ayata M., Komase K., Shingai M., Matsunaga I., Katayama Y., Ogura H. Mutations affecting transcriptional termination in the P gene end of subacute sclerosing panencephalitis viruses. J. Virol. 2002, 76:13062-13068.
4. Ayata M., Shingai M., Ning X., Matsumoto M., Seya T., Otani S., Seto T., Ohgimoto S., Ogura H. Effect of the alterations in the fusion protein of measles virus isolated from brains of patients with subacute sclerosing panencephalitis on syncytium formation. Virus Res. 2007, 130:260-268.
5. Ayata M., Takeuchi K., Takeda M., Ohgimoto S., Kato S., Sharma L.B., Tanaka M., Kuwamura M., Ishida H., Ogura H. The F gene of the Osaka-2 strain of measles virus derived from a case of subacute sclerosing panencephalitis is a major determinant of neurovirulence. J. Virol. 2010, 84:11189-11199.
6. Bhaskar A., Bala J., Varshney A., Yadava P. Expression of measles virus nucleoprotein induces apoptosis and modulates diverse functional proteins in cultured mammalian cells. PLoS One 2011, 6:e18765.
7. Billeter M.A., Cattaneo R. Molecular biology of defective measles viruses persisting in the human central nervous system. The Paramyxoviruses 1991, 323-345. Plenum Press, New York. D.W. Kingsbury (Ed.).
8. Cathomen T., Mrkic B., Spehner D., Drillien R., Naef R., Pavlovic J., Aguzzi A., Billeter M.A., Cattaneo R. A matrix-less measles virus is infectious and elicits extensive cell fusion: consequences for propagation in the brain. EMBO J. 1998, 17:3899-3908.
9. Cattaneo R., Rose J.K. Cell fusion by the envelope glycoproteins of persistent measles viruses which caused lethal human brain disease. J. Virol. 1993, 67:1493-1502.
10. Cattaneo R., Schmid A., Rebmann G., Baczko K., ter Meulen V., Bellini W.J., Rozenblatt S., Billeter M.A. Accumulated measles virus mutations in case of subacute sclerosing panencephalitis: interrupted matrix protein reading frame and transcription alteration. Virology 1986, 154:97-107.
11. Cattaneo R., Schmid A., Eschle D., Baczko K., ter Meulen V., Billeter M.A. Biased hypermutation and other genetic changes in defective measles virus in human brain infections. Cell 1988, 55:255-265.
12. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987, 162:156-159.
13. Darriba D., Taboada G.L., Doallo R., Posada D. jModelTest 2: more models, new heuristics and parallel computing. Nat. Methods 2012, 9:772.
14. Dyken P.R. Subacute sclerosing panencephalitis. Current status. Neurol. Clin. 1985, 3:179-196.
15. Eroglu E., Gokcil Z., Bek S., Ulas U.H., Ozdag M.F., Odabasi Z. Long-term follow-up of patients with adult onset subacute sclerosing panencephalitis. J. Neurol. Sci. 2008, 275:113-116.
16. EuroSurveillance editorial team, 2008. Measles once again endemic in the United Kingdom. Euro Surveill. 13, pii=18919.
17. Forčić D., Baričević M., Zgorelec R., Kružić V., Kaić B., Marušić Della Marina B., Cvitanović Šojat L., Tešović G., Mažuran R. Detection and characterization of measles virus strains in cases of subacute sclerosing panencephalitis in Croatia. Virus Res. 2004, 99:51-56.
18. Forcic D., Ivancic J., Baricevic M., Mahovlic V., Tesovic G., Bozinovic D., Gjenero Margan I., Mazuran R. Genetic characterization of wild type measles virus isolated in Croatia during 2003-2004 outbreak. J. Med. Virol. 2005, 75:307-312.
19. Furukawa K., Ayata M., Kimura M., Seto T., Matsunaga I., Murata R., Yamano T., Ogura H. Hemadsorption expressed by cloned H genes from subacute sclerosing panencephalitis (SSPE) viruses and their possible progenitor measles viruses isolated in Osaka, Japan. Microbiol. Immunol. 2001, 45:59-68.
20. Griffin D.E., Lin W.-H., Pan C.-H. Measles virus, immune control, and persistence. FEMS Microbiol. Rev. 2012, 36:649-662.
21. Guindon S., Gascuel O. A simple, fast and accurate method to estimate large phylogenies by maximum-likelihood. Syst. Biol. 2003, 52:696-704.
22. Hashiguchi T., Kajikawa M., Maita N., Takeda M., Kuroki K., Sasaki K., Kohda D., Yanagi Y., Maenaka K. Crystal structure of measles virus hemagglutinin provides insight into effective vaccines. Proc. Natl. Acad. Sci. USA 2007, 104:19535-19540.
23. Hirano A., Wang A.H., Gombart A.F., Wong T.C. The matrix proteins of neurovirulent subacute sclerosing panencephalitis virus and its acute measles progenitor are functionally different. Proc. Natl. Acad. Sci. USA 1992, 89:8745-8749.
24. Hu A., Cattaneo R., Schwartz S., Norrby E. Role of N-linked oligosaccharide chains in the processing and antigenicity of measles virus haemagglutinin protein. J. Gen. Virol. 1994, 75:1043-1052.
25. Jiang D., Ide Y., Nagano-Fujii M., Shoji I., Hotta H. Single-point mutations of a measles virus variant obtained from a patient with subacute sclerosing panencephalitis critically affect solubility and subcellular localization of the M protein and cell-free virus production. Microbes Infect. 2009, 11:467-475.
26. Kaic, B., Gjenero-Margan, I., Kurecic-Filipovic, S., Muscat, M., 2009. A measles outbreak in Croatia, 2008. Euro Surveill. 14, pii=19083.
27. Karlin D., Longi L., Canard B. Substitution of two residues in the measles virus nucleoprotein results in impaired self-association. Virology 2002, 302:420-432.
28. Komase K., Haga T., Yoshikawa Y., Sato T.A., Yamanouchi K. Molecular analysis of structural protein genes of the Yamagata-1 strain of defective subacute sclerosing panencephalitis virus. III. Nucleotide sequence of the hemagglutinin gene. Virus Genes 1990, 4:163-172.
29. Kühne M., Brown D.W.G., Jin L. Genetic variability of measles virus in acute and persistent infections. Infect. Genet. Evol. 2006, 6:269-276.
30. Larkin M.A., Blackshields G., Brown N.P., Chenna R., McGettigan P.A., McWilliam H., Valentin F., Wallace I.M., Wilm A., Lopez R., Thompson J.D., Gibson T.J., Higgins D.G. Clustal W and Clustal X version 2.0. Bioinformatics 2007, 23:2947-2948.
31. Lawrence D.M.P., Patterson C.E., Gales T.L., D'Orazio J.L., Vaughn M.M., Rall G.F. Measles virus spread between neurons reguires cell contact but not CD46 expression, syncytium formation or extracellular virus production. J. Virol. 2000, 74:1908-1918.
32. Mahadevan A., Vaidya S.R., Wairagkar N.S., Khedekar D., Kovoor J.M.E., Santosh V., Yasha T.C., Satishchandra P., Ravi V., Shankar S.K. Case of fulminant-SSPE associated with measles genotype D7 from India: an autopsy study. Neuropathology 2008, 28:621-626.
33. Makhortova N.R., Askovich P., Patterson C.E., Gechman L.A., Gerard N.P., Rall G.F. Neurokinin-1 enables measles virus trans-synaptic spread in neurons. Virology 2007, 326:235-244.
34. Mbugua F.M., Okoth F.A., Gray M., Kamau T., Kalu A., Eggers R., Borus P., Kombich J., Langat A., Maritim P., Lesiamon J., Tipples G.A. Molecular epidemiology of measles in Kenya. J. Med. Virol. 2003, 71:599-604.
35. Mosquera, M.M., de Ory, F., Echevarría, J.E., The network of laboratories of the spanish national measles elimination plan, 2010. Measles virus genotyping and circulating genotypes. Open Vaccine J. 3, 76-85.
36. Moulin E., Beal V., Jeantet D., Horvat B., Wild T.F., Waku-Kouomou D. Molecular characterization of measles virus strains causing subacute sclerosing panencephalitis in France in 1977 and 2007. J. Med. Virol. 2011, 83:1614-1623.
37. Ning X., Ayata M., Kimura M., Komase K., Furukawa K., Seto T., Ito N., Shingai M., Matsunaga I., Yamano T., Ogura H. Alterations and diversity in the cytoplasmic tail of the fusion protein of subacute sclerosing panencephalitis virus strains isolated in Osaka, Japan. Virus Res. 2002, 86:123-131.
38. Obeid O.E., Partidos C.D., Steward M.W. Analysis of the antigenic profile of measles virus hemagglutinin in mice and humans using overlapping synthetic peptides. Virus Res. 1994, 32:69-84.
39. Okuno Y., Nakao T., Ishida N., Konno T., Mizutani H., Fukuyama Y., Sato T., Isomura S., Ueda S., Kitamura I., Kaji M. Incidence of subacute sclerosing panencephalitis following measles and measles vaccination in Japan. Int. J. Epidemiol. 1989, 18:684-689.
40. Patterson J.B., Cornu T.I., Redwine J., Dales S., Lewicki H., Holz A., Thomas D., Billeter M.A., Oldstone M.B. Evidence that the hypermutated M protein of a subacute sclerosing panencephalitis measles virus actively contributes to the chronic progressive CNS disease. Virology 2001, 291:215-225.
41. Prashanth L.K., Taly A.B., Ravi V., Sinha S., Rao S. Long-term survival in subacute sclerosing panencephalitis: an enigma. Brain. Dev. 2006, 28:447-452.
42. Rima B.K., Duprex P. Molecular mechanisms of measles virus persistence. Virus Res. 2005, 111:132-147.
43. Rima B.K., Earle J.A., Baczko K., ter Meulen V., Liebert U.G., Carstens C., Carabaña J., Caballero M., Celma M.L., Fernandez-Muñoz R. Sequence divergence of measles virus haemagglutinin during natural evolution and adaptation to cell culture. J. Gen. Virol. 1997, 78:97-106.
44. Rota J.S., Hummel K.B., Rota P.A., Bellini W.J. Genetic variability of the glycoprotein genes of current wild-type measles isolates. Virology 1992, 188:135-142.
45. Rota P.A., Featherstone D.A., Bellini W.J. Molecular epidemiology of measles virus. Measles-Pathogenesis and Control 2009, 129-150. Springer-Verlag, Berlin Heidelberg. D.E. Griffin, M.B.A. Oldstone (Eds.).
46. Santibatinez S., Tischer A., Heider A., Siedler A., Hengel H. Rapid replacement of endemic measles virus genotypes. J. Gen. Virol. 2002, 83:2699-2708.
47. Santoshkumar B., Radhakrishnan K. Substantial spontaneous long-term remission in subacute sclerosing panencephalitis (SSPE). J. Neurol. Sci. 1998, 154:83-88.
48. Schmid A., Spielhofer P., Cattaneo R., Baczko K., ter Meulen V., Billeter M.A. Subacute sclerosing panencephalitis is typically characterized by alterations in fusion protein cytoplasmic domain of the persisting measles virus. Virology 1992, 188:910-915.
49. Schneider-Schaulies J., Niewiesk S., Schneider-Schaulies S., ter Meulen V. Measles virus in the CNS: the role of viral and host factors for the establishment and maintenance of a persistent infection. J. Neurovirol. 1999, 5:613-622.
50. Tahara M., Takeda M., Shirogane Y., Hashiguchi T., Ohno S., Yanagi Y. Measles virus infects both polarized epithelial and immune cells by using distinctive receptor-binding sites on its hemagglutinin. J. Virol. 2008, 82:4630-4637.
51. Takayama I., Sato H., Watanabe A., Omi-Furutani M., Sugai A., Kanki K., Yoneda K., Kai C. The nucleocapsid protein of measles virus blocks host interferon response. Virology 2012, 424:45-55.
52. Tamura K., Peterson D., Peterson N., Stecher G., Nei M., Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 2011, 28:2731-2739.
53. Vatev N.T., Stoycheva M.V., Petrov A.I. Reemergence of measles in Bulgaria: a large outbreak in Plovdiv, 2010. Braz. J. Infect. Dis. 2011, 15:613-616.
54. Vilibic Cavlek T., Ljubin Sternak S., Kaic B., Zarkovic K., Marusic Della Marina B., Cvitanovic Sojat L., Basnec A., Mlinaric Galinovic G. Subacute Sclerosing panencephalitis in Croatia (1994-2004). Acta Microbiol. Immunol. Hung. 2007, 54:57-63.
55. WHO, 1998. Expanded programme on immunization (EPI). Standardization of the nomenclature for describing the genetic characteristics of wild-type measles viruses. Wkly. Epidemiol. Rec. 35, 265-269.
56. WHO Regional Committee for Europe, 55th Session, 2005. Resolution: Strengthening national immunization systems through measles and rubella elimination and prevention of congenital rubella infection in WHO's European Region. WHO, publication EUR/RC55/R7.
57. WHO, 2006. Global advisory committee on vaccine safety, 1-2 December 2005. Wkly. Epidemiol. Rec. 81, 15-19.
58. WHO Regional Committee for Europe, 60th Session, 2010. Resolution: Renewed commitment to elimination of measles and rubella and prevention of congenital rubella syndrome by 2015 and sustained support for polio-free status in the WHO European Region.
59. WHO, 2011. Increased transmission and outbreaks of measles, European Region, 2011. Wkly. Epidemiol. Rec. 86, 559-564.
60. WHO, 2012. Measles virus nomenclature update: 2012. Wkly. Epidemiol. Rec. 89, 73-80.
61. Wight C., Jin L., Nelson C.S., Cosby S.L., Padfield C.J. Case report: an autopsy-proven case of fulminant subacute sclerosing panencephalitis. Neuropathol. Appl. Neurobiol. 2003, 29:312-316.
62. Woelk C.H., Pybus O.G., Jin L., Brown D.W.G., Holmes E.C. Increased positive selection pressure in persistent (SSPE) versus acute measles virus infections. J. Gen. Virol. 2002, 83:1419-1430.
63. Wong T.C., Ayata M., Ueda S., Hirano A. Role of biased hypermutation of subacute sclerosing panencephalitis virus from progenitor acute measles virus. J. Virol. 1991, 65:2191-2199.